Organization Overview
Alternative names
allogeneic cd34+ cells (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (1 trial)
allogeneic stem cells (1 trial)
colchicine (colbenemid) (1 trial)
cyclophosphamide (cytoxan) (2 trials)
cytarabine (cytosar-u) (1 trial)
daunorubicin (cerubidine) (1 trial)
durvalumab (imfinzi) (1 trial)
Adenocarcinoma (Phase 2)
Brain Neoplasms (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Embolism (Phase 3)
Fallopian Tube Neoplasms (Phase 2)
Fatigue (Phase 2)
Fever (Phase 2)
Glioblastoma (Phase 2)
Hematologic Diseases (Phase 2)
Hypokalemia (Phase 4)
Leukemia (Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Lung Neoplasms (Phase 2)
Neoplasm Metastasis (Phase 1)
Neoplasms (Phase 2)
Neoplasms, Second Primary (Phase 1)
Pain, Postoperative (Phase 4)
Peritoneal Neoplasms (Phase 2)
Phlebitis (Phase 4)
Pulmonary Embolism (Phase 3)
Thromboembolism (Phase 3)
Uterine Cervical Neoplasms (Phase 2)
Wounds and Injuries (Phase 3)